Magnetic resonance imaging of cardiac tumors: experience of a tertiary medical center by Ian C Chang et al.
POSTER PRESENTATION Open Access
Magnetic resonance imaging of cardiac tumors:
experience of a tertiary medical center
Ian C Chang*, Helina Kassahun, Uma Valeti
From 16th Annual SCMR Scientific Sessions
San Francisco, CA, USA. 31 January - 3 February 2013
Background
Cardiac tumors are rare, with estimated prevalence of
0.002-0.3% at autopsy. Symptoms and prognosis of
cardiac tumors depend on size, location, and intrinsic
aggressiveness. Cardiac magnetic resonance (CMR) ima-
ging is non-invasive and offers unsurpassed soft-tissue
characterization. In this study, we sought to examine
the CMR imaging of various cardiac tumors and identify
radiologic features of clinical relevance for diagnosis,
prognosis, and treatment of the patients.
Methods
We identified patients referred to the University of
Minnesota in the last 5 years (January, 1, 2007-August
31, 2012) for cardiac masses who received CMR imaging
and had final diagnoses either by histopathology or
clinical evidence. CMR was performed on 1.5T scanners
using standardized protocols. An experienced level 3
physician interpreted the CMR studies. Findings on
CMR imaging were characterized and correlated with
multimodality studies including echocardiography, com-
puted tomography, and positron emission tomography.
We correlated the imaging features with clinicopathol-
ogy and compared to those reported in the literature.
Significant clinical impact was defined as establishing a
new diagnosis, affecting the decision on invasive surgical
procedures, or causing medication change. Clinical
impact was determined from chart review.
Results
We evaluated 32 patients (aged 22-86 years) presenting
with cardiac masses. Diagnoses included primary benign
tumor (N=4, 12.5%), primary malignant tumor (N=3,
9.4%), metastasis (N=7, 21.9%), thrombus (N=9, 28.1%),
and pseudotumor (N=9, 28.1%). Pseudotumor included
pericardial cyst, calcified mitral annulus, atrial septal
defect occlusion device, hiatal hernia, abscess, and
lipomatous hypertrophy. Imaging features commonly
seen in malignant tumors included tissue heterogeneity,
large size (> 5 cm), the involvement of more than one
chamber and adjacent structures, and the presence of
contrast enhancement. In addition, we identified a
previously unreported pattern of tumor perfusion and
contrast enhancement in aggressive malignant tumors;
this enhancement gradient could represent varying
degrees of vascularity and tumor necrosis. Tumors and
thrombi could be differentiated (77.8%) by thrombus
correlates: characteristic locations, adjacent scarred
myocardium on delayed enhancement imaging, and lack
of contrast enhancement. CMR imaging had a signifi-
cant clinical impact in 71.9% of patients and established
a new diagnosis in 21.9%.
Conclusions
CMR imaging of cardiac masses often makes significant
clinical impact by providing invaluable information facil-
itating accurate diagnosis, prognosis and management.
Besides commonly reported features, an enhancement
gradient on CMR could potentially be used to identify
an aggressive malignant cardiac tumor. This study
further supports CMR imaging as a useful and clinically
relevant modality for cardiac tumor evaluation.
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Figure 1 Patient with metastatic undifferentiated sarcoma to the heart (arrow) undergoing CMR imaging. T2-weighted imaging (top left) shows
varying signal intensity with more edema in the periphery. Resting perfusion imaging (top right: short axis view, bottom left: long axis view)
shows a gradient perfusion with the peripheral portion of the mass having less vascularity and perfusion. Delayed enhancement imaging
(bottom right) shows a gradient enhancement suggesting more necrosis along the outer portion of the mass.
Figure 2 CMR imaging of a patient with metastatic melanoma (arrow) invading the right atrioventricular groove from the mediastinum. Delayed
enhancement imaging (left: four chamber view, right: show axis view) shows a gradient enhancement, which suggests more necrosis towards
the edges away from the vascular supply of the metastatic mass.
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